This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1rek

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1rek.gif|left|200px]]
+
{{Seed}}
 +
[[Image:1rek.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1rek| PDB=1rek | SCENE= }}
{{STRUCTURE_1rek| PDB=1rek | SCENE= }}
-
'''Crystal structure of cAMP-dependent protein kinase complexed with balanol analog 8'''
+
===Crystal structure of cAMP-dependent protein kinase complexed with balanol analog 8===
-
==Overview==
+
<!--
-
The protein kinase family is a prime target for therapeutic agents, since unregulated protein kinase activities are linked to myriad diseases. Balanol, a fungal metabolite consisting of four rings, potently inhibits Ser/Thr protein kinases and can be modified to yield potent inhibitors that are selective-characteristics of a desirable pharmaceutical compound. Here, we characterize three balanol analogues that inhibit cyclic 3',5'-adenosine monophosphate-dependent protein kinase (PKA) more specifically and potently than calcium- and phospholipid-dependent protein kinase (PKC). Correlation of thermostability and inhibition potency suggests that better inhibitors confer enhanced protection against thermal denaturation. Crystal structures of the PKA catalytic (C) subunit complexed to each analogue show the Gly-rich loop stabilized in an "intermediate" conformation, disengaged from important phosphoryl transfer residues. An analogue that perturbs the PKA C-terminal tail has slightly weaker inhibition potency. The malleability of the PKA C subunit is illustrated by active site residues that adopt alternate rotamers depending on the ligand bound. On the basis of sequence homology to PKA, a preliminary model of the PKC active site is described. The balanol analogues serve to test the model and to highlight differences in the active site local environment of PKA and PKC. The PKA C subunit appears to tolerate balanol analogues with D-ring modifications; PKC does not. We attribute this difference in preference to the variable B helix and C-terminal tail. By understanding the details of ligand binding, more specific and potent inhibitors may be designed that differentiate among closely related AGC protein kinase family members.
+
The line below this paragraph, {{ABSTRACT_PUBMED_14705934}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 14705934 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_14705934}}
==About this Structure==
==About this Structure==
Line 35: Line 39:
[[Category: Protein kinase]]
[[Category: Protein kinase]]
[[Category: Specifity determinant]]
[[Category: Specifity determinant]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 07:23:59 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Jul 27 12:56:19 2008''

Revision as of 09:56, 27 July 2008

Image:1rek.png

Template:STRUCTURE 1rek

Crystal structure of cAMP-dependent protein kinase complexed with balanol analog 8

Template:ABSTRACT PUBMED 14705934

About this Structure

1REK is a Single protein structure of sequence from Mus musculus. Full crystallographic information is available from OCA.

Reference

Balanol analogues probe specificity determinants and the conformational malleability of the cyclic 3',5'-adenosine monophosphate-dependent protein kinase catalytic subunit., Akamine P, Madhusudan, Brunton LL, Ou HD, Canaves JM, Xuong NH, Taylor SS, Biochemistry. 2004 Jan 13;43(1):85-96. PMID:14705934

Page seeded by OCA on Sun Jul 27 12:56:19 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1rek"
Personal tools